How Astellas Pharma Navigates Japan’s 2026 Pharma Landscape & Patent Challenges
Japanese pharma faces price pressure and patent cliffs; Astellas can boost margins and growth by targeting high‑impact biologics, strategic M&A, and robust market‑access tactics.
4 minutes to read